Heparanase Enzyme in Chronic Inflammatory Bowel Disease and Colon Cancer

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2012 Feb 15

PMID 22331282

Citations 20

Authors

Esther Hermano

Immanuel Lerner

Michael Elkin

Affiliations

Soon will be listed here.

Abstract

Heparanase is the sole mammalian endoglycosidase that cleaves heparan sulfate, the key polysaccharide of the extracellular matrix and basement membranes. Enzymatic cleavage of heparan sulfate profoundly affects a variety of physiological and pathological processes, including morphogenesis, neovascularization, inflammation, and tumorigenesis. Critical involvement of heparanase in colorectal tumor progression and metastatic spread is widely documented; however, until recently a role for heparanase in the initiation of colon carcinoma remained underappreciated. Interestingly, the emerging data that link heparanase to chronic inflammatory bowel conditions, also suggest contribution of the enzyme to colonic tumor initiation, at least in the setting of colitis-associated cancer. Highly coordinated interplay between intestinal heparanase and immune cells (i.e., macrophages) preserves chronic inflammatory conditions and creates a tumor-promoting microenvironment. Here we review the action of heparanase in colon tumorigenesis and discuss recent findings, pointing to a role for heparanase in sustaining immune cell-epithelial crosstalk that underlies intestinal inflammation and the associated cancer.

Citing Articles

Genetic Engineering Bacillus thuringiensis Enable Melanin Biosynthesis for Anti-Tumor and Anti-Inflammation.

Chen M, Guo B, Cheng H, Wang W, Jin J, Zhang Y Adv Sci (Weinh). 2024; 11(36):e2308506.

PMID: 38943265 PMC: 11423088. DOI: 10.1002/advs.202308506.

Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase.

Abecassis A, Hermano E, Sheva K, Rubinstein A, Elkin M, Meirovitz A Biomedicines. 2023; 11(3).

PMID: 36979689 PMC: 10045137. DOI: 10.3390/biomedicines11030710.

Role of heparinase in the gastrointestinal dysfunction of sepsis (Review).

Chen T, Lv J, Chen L, Gao Y, Liu L Exp Ther Med. 2021; 23(2):119.

PMID: 34970342 PMC: 8713170. DOI: 10.3892/etm.2021.11042.

-Induced Heparanase Promotes Colonization and Gastritis.

Tang L, Tang B, Lei Y, Yang M, Wang S, Hu S Front Immunol. 2021; 12:675747.

PMID: 34220822 PMC: 8248549. DOI: 10.3389/fimmu.2021.675747.

Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy.

Berdiaki A, Neagu M, Giatagana E, Kuskov A, Tsatsakis A, N Tzanakakis G Biomolecules. 2021; 11(3).

PMID: 33800172 PMC: 8001210. DOI: 10.3390/biom11030395.

References

Terzic J, Grivennikov S, Karin E, Karin M . Inflammation and colon cancer. Gastroenterology. 2010; 138(6):2101-2114.e5. DOI: 10.1053/j.gastro.2010.01.058. View

Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I . Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol. 2002; 12(3):173-86. DOI: 10.1016/S1044-579X(02)00021-4. View

Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S . Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 1996; 39(1):87-92. PMC: 1383238. DOI: 10.1136/gut.39.1.87. View

Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J . Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer. 2002; 86(8):1270-5. PMC: 2375333. DOI: 10.1038/sj.bjc.6600232. View

Torkvist L, Thorlacius H, Sjoqvist U, Bohman L, Lapidus A, Flood L . Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther. 1999; 13(10):1323-8. DOI: 10.1046/j.1365-2036.1999.00599.x. View

Herszenyi L, Miheller P, Tulassay Z . Carcinogenesis in inflammatory bowel disease. Dig Dis. 2007; 25(3):267-9. DOI: 10.1159/000103898. View

Xu X, Ding J, Rao G, Shen J, Prinz R, Rana N . Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Hum Reprod. 2007; 22(4):927-37. DOI: 10.1093/humrep/del483. View

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

Zhang Y, Li L, Wang Y, Zhang J, Wei G, Sun Y . Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun. 2007; 358(1):124-9. DOI: 10.1016/j.bbrc.2007.04.068. View

10.

Clevers H . Colon cancer--understanding how NSAIDs work. N Engl J Med. 2006; 354(7):761-3. DOI: 10.1056/NEJMcibr055457. View

11.

Gotte M . Syndecans in inflammation. FASEB J. 2003; 17(6):575-91. DOI: 10.1096/fj.02-0739rev. View

12.

Maxhimer J, Quiros R, Stewart R, Dowlatshahi K, Gattuso P, Fan M . Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery. 2002; 132(2):326-33. DOI: 10.1067/msy.2002.125719. View

13.

Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, PECKER I . Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001; 61(12):4655-9. View

14.

Lider O, Mekori Y, Miller T, Vlodavsky I, Baharav E, Cohen I . Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol. 1990; 20(3):493-9. DOI: 10.1002/eji.1830200306. View

15.

Smith P, Ochsenbauer-Jambor C, Smythies L . Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev. 2005; 206:149-59. DOI: 10.1111/j.0105-2896.2005.00288.x. View

16.

Becker C, Fantini M, Wirtz S, Nikolaev A, Lehr H, Galle P . IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle. 2005; 4(2):217-20. View

17.

Doviner V, Maly B, Kaplan V, Gingis-Velitski S, Ilan N, Vlodavsky I . Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod Pathol. 2006; 19(6):878-88. DOI: 10.1038/modpathol.3800603. View

18.

Miao H, Elkin M, Aingorn E, Stein C, Vlodavsky I . Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999; 83(3):424-31. DOI: 10.1002/(sici)1097-0215(19991029)83:3<424::aid-ijc20>3.0.co;2-l. View

19.

Kramer K, Yost H . Heparan sulfate core proteins in cell-cell signaling. Annu Rev Genet. 2003; 37:461-84. DOI: 10.1146/annurev.genet.37.061103.090226. View

20.

Bernfield M, Gotte M, Park P, Reizes O, Fitzgerald M, Lincecum J . Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 2000; 68:729-77. DOI: 10.1146/annurev.biochem.68.1.729. View